Pietro Sormanni

University of Cambridge

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Clemens Kaminski

Lecturer / Reader / Professor of Chemical Physics

University of Cambridge

UNITED KINGDOM

View details

Francesco Antonio Aprile

Lecturer in Chemistry

Imperial College London

UNITED KINGDOM

View details

David O'Connell

Associate Professor

Dublin City University

IRELAND

View details

Stefano Ricagno

Full Professor

University of Milan

ITALY

View details

Charlotte M Deane

University of Oxford

UNITED KINGDOM

View details

Ellen AA Nollen

NETHERLANDS

View details

Margherita Romeo

Mario Negri Institute for pharmacological research

ITALY

View details

Philip Ward

University of Oxford

UNITED KINGDOM

View details

Lucile Moynié

Rosalind Franklin Institute

UNITED KINGDOM

View details

Ryan Limbocker

Assistant Professor

United States Military Academy

UNITED STATES

View details

Tatsuya Ikenoue

University of Tokyo

JAPAN

View details

Gonçalo Bernardes

Professor of Chemical Biology

University of Cambridge Department of Medicine

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pietro Sormanni

Research Interests

Explore related searches

Contact this professor

Articles (18)

Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMelt

Automated optimization of the solubility of a hyper-stable α-amylase

Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV

Automated optimisation of solubility and conformational stability of antibodies and proteins

Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes.

Fragment-based computational design of antibodies targeting structured epitopes

Conformational Entropy as a Potential Liability of Computationally Designed Antibodies

Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics

An aggregation inhibitor specific to oligomeric intermediates of Aβ42 derived from phage display libraries of stable, small proteins

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease.

Systematic Activity Maturation of a Single-Domain Antibody with Non-canonical Amino Acids through Chemical Mutagenesis

Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases

Rationally Designed Bicyclic Peptides Prevent the Conversion of Aβ42 Assemblies Into Fibrillar Structures

Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers

Rational design of a conformation-specific antibody for the quantification of Aβ oligomers

A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease

Inherent Biophysical Properties Modulate the Toxicity of Soluble Amyloidogenic Light Chains

Biochemical and biophysical comparison of human and mouse beta-2 microglobulin reveals the molecular determinants of low amyloid propensity

Collaborators (12)

Clemens Kaminski

Francesco Antonio Aprile

David O'Connell

Stefano Ricagno

Charlotte M Deane

Ellen AA Nollen

Margherita Romeo

Philip Ward

Lucile Moynié

Ryan Limbocker

Tatsuya Ikenoue

Gonçalo Bernardes

Make your next move.